.png)
Next-Gen
In Vitro Models
For Research & Drug Development
95% of new cancer drugs fail during clinical trials.
Drug development has also become slower and more expensive over time in a phenomenon known as Erooms Law. One of the root causes of these problems is that the tools researchers use for efficacy testing, such as 2D cell cultures and murine models, do not accurately depict human biology.
_edited_edi.png)
OUR SOLUTION
3D CULTURE PLATFORMS
EZ-Seed Plate
ADVANTAGES
-
Easily create up to 45 spheroids from a single pipette step.
-
Uniform spheroids for experimental consistency.
-
No risk of losing or damaging spheroids during media changes.
-
Effortless immunostaining and imaging.
-
In situ IHC and H&E analysis.
3-in-1 Plate
ADVANTAGES
-
Spheroid formation + extracellular matrix + drug testing + analysis. All-in-one platform.
Uniform spheroids for experimental consistency.
-
No risk of losing or damaging spheroids during media changes.
-
Lower cell requirements reduces the need to passage cells for organoid formation.
-
One spheroid per microwell. No crosstalk between the models.
-
Easily image spheroids in situ.
-
In situ IHC and H&E analysis.
Our Partners
Research Institutes and Universities
Pre-clinical CROs
Pharma and Drug Developers
2
1
10
Rewriting Erooms Law.
